Literature DB >> 3301481

Reduction of platelet aggregation induced by euglycaemic insulin clamp.

K Hiramatsu, H Nozaki, S Arimori.   

Abstract

To examine the effect of serum insulin independent of the level of blood glucose in vivo on platelet aggregation in healthy individuals, a euglycaemic insulin clamp was applied up to 4 h. During the clamp, blood glucose at 5.0 mmol/l and insulin levels at 100 microU/ml were maintained. Blood samples were drawn before, 2 and 4 h after the start of the insulin clamp. The platelet aggregation induced by 1 mumol/l and 2 mumol/l ADP, 1 microgram/ml collagen and 2.7 mumol/l epinephrine was measured in the blood samples. Platelet aggregation induced by adenosine diphosphate, collagen and epinephrine in the 4 h sample was significantly reduced from the pre-clamp value of 8.4% to 3.9% (p less than 0.05), 26.2% to 7.0% (p less than 0.01) and 31.8% to 9.1% (p less than 0.01), respectively. On the other hand, when the same individuals were infused with physiological saline and blood glucose (4.4 mmol/l) and insulin level (10 mIU/l) were kept within normal values, there was no difference between the values of induced platelet aggregation in samples drawn before and during the insulin infusion. It was concluded that hyperinsulinaemia reduces platelet aggregation in vivo when euglycaemia was maintained.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301481     DOI: 10.1007/BF00299023

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Increased platelet aggregation in early diabetus mellitus.

Authors:  J Sagel; J A Colwell; L Crook; M Laimins
Journal:  Ann Intern Med       Date:  1975-06       Impact factor: 25.391

3.  Platelet aggregation in diabetes mellitus and the effect of insulin in vivo on aggregation.

Authors:  A A Hassanein; T A el-Garf; Z el-Baz
Journal:  Thromb Diath Haemorrh       Date:  1972-02-29

4.  Platelet aggregation after strict metabolic control using the artificial pancreas.

Authors:  D Giugliano; L Misso; A Tirelli; L Coppola; P Di Pinto; R Torella
Journal:  Diabetologia       Date:  1982-12       Impact factor: 10.122

5.  Platelet adhesion and aggregation in diabetes mellitus.

Authors:  J A Colwell; R M Nair; P V Halushka; C Rogers; A Whetsell; J Sagel
Journal:  Metabolism       Date:  1979-04       Impact factor: 8.694

6.  In vivo stimulation of low-density lipoprotein degradation by insulin.

Authors:  T Mazzone; D Foster; A Chait
Journal:  Diabetes       Date:  1984-04       Impact factor: 9.461

7.  Comparison of platelet thromboxane synthesis in diabetic patients on conventional insulin therapy and continuous insulin infusions.

Authors:  J W McDonald; J Dupre; N W Rodger; M C Champion; C D Webb; M Ali
Journal:  Thromb Res       Date:  1982-12-15       Impact factor: 3.944

8.  Glucose clamp technique: a method for quantifying insulin secretion and resistance.

Authors:  R A DeFronzo; J D Tobin; R Andres
Journal:  Am J Physiol       Date:  1979-09

9.  Induced basal normoglycemia and altered platelet aggregation in non-insulin-dependent diabetes.

Authors:  R J Evans; J Lane; R R Holman; R C Turner
Journal:  Diabetes Care       Date:  1982 Jul-Aug       Impact factor: 19.112

Review 10.  Red cell deformability, platelet aggregation, and insulin action.

Authors:  P Vague; I Juhan
Journal:  Diabetes       Date:  1983-05       Impact factor: 9.461

View more
  8 in total

1.  Effect of alpha 2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  H Takeda; H Kishikawa; M Shinohara; T Miyata; K Suzaki; H Fukushima; K Ichinose; M Shichiri
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

Review 2.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

3.  Wine consumption reduced postprandial platelet sensitivity against platelet activating factor in healthy men.

Authors:  Marianna N Xanthopoulou; Konstantia Kalathara; Sophia Melachroinou; Kalliopi Arampatzi-Menenakou; Smaragdi Antonopoulou; Mary Yannakoulia; Elizabeth Fragopoulou
Journal:  Eur J Nutr       Date:  2016-03-02       Impact factor: 5.614

4.  Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective.

Authors:  Nicholaos Kakouros; Jeffrey J Rade; Antonios Kourliouros; Jon R Resar
Journal:  Int J Endocrinol       Date:  2011-08-21       Impact factor: 3.257

5.  Platelet function in the postprandial period.

Authors:  Helmut Sinzinger; Robert Berent
Journal:  Thromb J       Date:  2012-09-03

Review 6.  The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance.

Authors:  Isabella Russo
Journal:  Scientifica (Cairo)       Date:  2012-08-30

7.  TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction.

Authors:  Riobaldo Cintra; Filipe A Moura; Luiz S F Carvalho; Mauricio Daher; Simone N Santos; Ana P R Costa; Valeria N Figueiredo; Joalbo M Andrade; Francisco A R Neves; Jose C Quinaglia E Silva; Andrei C Sposito
Journal:  BBA Clin       Date:  2016-04-02

Review 8.  The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation.

Authors:  Albino Carrizzo; Carmine Izzo; Marco Oliveti; Antonia Alfano; Nicola Virtuoso; Mario Capunzo; Paola Di Pietro; Mariaconsiglia Calabrese; Eros De Simone; Sebastiano Sciarretta; Giacomo Frati; Serena Migliarino; Antonio Damato; Mariateresa Ambrosio; Francesco De Caro; Carmine Vecchione
Journal:  Int J Mol Sci       Date:  2018-09-28       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.